- Fund Type: Variable Annuity
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
VALIC I - Health Sciences Fund
+ Add to WatchlistVCHSX:US
16.44 USD 0.09 0.55%As of 09:29:30 ET on 05/23/2013.
Snapshot for VALIC I - Health Sciences Fund (VCHSX)
| Year To Date: | +21.60% | 3-Month: | +11.53% | 3-Year: | +28.34% | 52-Week Range: | 11.57 - 16.69 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.49% | 1-Year: | +38.46% | 5-Year: | +15.51% | Beta vs SPX: | 0.99 |
Fund Profile & Information for VCHSX
Valic Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine or the life sciences.
| Inception Date: | 09-01-2006 | Telephone: | 1-800-448-2542 |
|---|---|---|---|
| Managers: | TAYMOUR R TAMADDON | ||
| Web Site: | - | ||
Fundamentals for VCHSX
| NAV | (on 2013-05-23) 16.44 |
|---|---|
| Assets (M) | (on 2013-04-30) 397.07 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for VCHSX
| Dividend Type | Short Term Cap Gain |
|---|---|
| Dividend Frequency | Irreg |
| Last Dividend Net | (on 2012-12-10) 0.02 |
| Dividend Yield (ttm) | 5.12 |
Fees & Expenses for VCHSX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.00 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.17 |
Top Fund Holdings for VCHSX
Filing Date: 02/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Alexion Pharmaceuticals Inc | 204,740 | 17,759,148 | 4.978% |
| Catamaran Corp | 311,140 | 16,711,329 | 4.684% |
| Gilead Sciences Inc | 361,300 | 15,431,123 | 4.325% |
| Pharmacyclics Inc | 132,700 | 11,648,406 | 3.265% |
| Valeant Pharmaceuticals Intern | 153,033 | 10,323,606 | 2.894% |
| Incyte Corp Ltd | 326,600 | 7,250,520 | 2.032% |
| UnitedHealth Group Inc | 129,400 | 6,916,430 | 1.939% |
| Regeneron Pharmaceuticals Inc | 36,200 | 6,045,400 | 1.694% |
| Celgene Corp | 55,940 | 5,771,889 | 1.618% |
| McKesson Corp | 54,000 | 5,731,020 | 1.606% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page